The advantages of PD1 activating chimeric receptor (PD1-ACR) engineered lymphocytes for PDL1(+) cancer therapy
about
Immune Evasion Strategies of GlioblastomaThe effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune responseCommensal bacterial modulation of the host immune response to ameliorate pain in a murine model of chronic prostatitis.
P2860
The advantages of PD1 activating chimeric receptor (PD1-ACR) engineered lymphocytes for PDL1(+) cancer therapy
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The advantages of PD1 activati ...... tes for PDL1(+) cancer therapy
@ast
The advantages of PD1 activati ...... tes for PDL1(+) cancer therapy
@en
The advantages of PD1 activati ...... tes for PDL1(+) cancer therapy
@nl
type
label
The advantages of PD1 activati ...... tes for PDL1(+) cancer therapy
@ast
The advantages of PD1 activati ...... tes for PDL1(+) cancer therapy
@en
The advantages of PD1 activati ...... tes for PDL1(+) cancer therapy
@nl
prefLabel
The advantages of PD1 activati ...... tes for PDL1(+) cancer therapy
@ast
The advantages of PD1 activati ...... tes for PDL1(+) cancer therapy
@en
The advantages of PD1 activati ...... tes for PDL1(+) cancer therapy
@nl
P2093
P2860
P1476
The advantages of PD1 activati ...... tes for PDL1(+) cancer therapy
@en
P2093
Chao Zhang
Donghui Zheng
Qingguo Li
Wenxuan Ni
Xiaojun Feng
Xiaolong Tang
Yong Liang
P2860
P304
P407
P50
P577
2015-03-15T00:00:00Z